Jounce Therapeutics

Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
Tue, 04/11/23 - 07:18 pm
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
Yahoo/Reuters
Tue, 03/28/23 - 10:18 am
Jounce Therapeutics
M&A
Concentra Biosciences
layoffs
Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx
BioSpace
Wed, 03/15/23 - 11:29 am
Jounce Therapeutics
Redx
Concerta
M&A
Jounce Slashes 57% of Staff, Drops Assets in Stock Merger with Redx
BioSpace
Fri, 02/24/23 - 09:18 am
Jounce Therapeutics
Redx
M&A
layoffs
Conditions are ripe for reverse mergers
EP Vantage
Fri, 02/24/23 - 08:48 am
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
Gilead buys remaining rights to Jounce’s immunotherapy GS-1811
Medical Marketing and Media
Wed, 12/28/22 - 08:39 pm
Gilead Sciences
Jounce Therapeutics
GS-1811
Jounce’s latest setback dampens outlook for another cancer immunotherapy target
BioPharma Dive
Tue, 08/30/22 - 06:10 pm
Jounce Therapeutics
lung cancer
cancer immunotherapy
vopratelimab
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
BioSpace
Sat, 01/16/21 - 11:57 pm
JPMHC 2021
intravenous immunoglobulin
IDEAYA Biosciences
Jounce Therapeutics
Puma Biotechnology
Three Biotechs Shutter Clinical Programs After Futility Analysis or Failed Trials
BioSpace
Tue, 11/3/20 - 09:29 pm
Jounce Therapeutics
vopratelimab
Santhera
vamorolone
Puldysa
Aurinia Pharmaceuticals
FOS
Jounce shares crash after it abandons immunotherapy combination trial
Pharmaforum
Tue, 11/3/20 - 10:24 am
Jounce Therapeutics
non-small cell lung cancer
Bristol-Myers Squibb
Yervoy
After Bristol snub, Gilead pens $120M upfront, $685M in biobucks for early Jounce cancer program
Fierce Biotech
Tue, 09/1/20 - 10:59 am
Jounce Therapeutics
Gilead Sciences
Bristol-Myers Squibb
biobucks
immuno-oncology
Bristol's Celgene merger sees it bounce Jounce drug pact
Fierce Biotech
Fri, 06/5/20 - 10:43 am
Bristol-Myers Squibb
Celgene
Jounce Therapeutics
M&A
immuno-oncology
The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus
Yahoo/Benzinga
Mon, 02/3/20 - 10:37 am
earnings
Forty Seven
Jounce Therapeutics
Catalyst Biosciences
Kodiak Sciences
Adverum Biotechnologies
IPOs
Beam Therapeutics
Why wait? Celgene restructures a big Jounce pact — zeroing in on new I/O pathway with $530M deal and bumping ICOS
Endpoints
Tue, 07/23/19 - 07:53 pm
Celgene
Jounce Therapeutics
JTX-8064
macrophages
Jounce seeking tumor-agnostic approach for ICOS agonist
BioCentury
Sat, 03/9/19 - 12:18 pm
Jounce Therapeutics
ICOS agonist
JTX-2011
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
M&A
Bristol-Myers Squibb
Celgene
Vividion Therapeutics
Evotec
Prothena
Anokion
Skyhawk Therapeutics
Dragonfly Therapeutics
BeiGene
Agios Pharmaceuticals
Jounce Therapeutics
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Celgene
M&A
Juno Therapeutics
Kite Therapeutics
Bluebird Bio
Agios Pharmaceuticals
Jounce Therapeutics
BieGene
Acceleron
ASCO18: Jounce plummets further on weak efficacy data
Biopharma Dive
Mon, 06/4/18 - 10:16 pm
Jounce Therapeutics
ASCO 2018
JTX-2011
solid tumors
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
ASCO 2018
European Society of Cardiology
TherapeuticsMD
Abiomed
Incyte
Bluebird Bio
Celgene
Syndax
Loxo Oncology
Exelixis
Karyopharm
Endocyte
Celldex Therapeutics
Jounce Therapeutics
Bristol-Myers Squibb
Nektar
Winners and Losers From the Biggest Cancer Meeting of the Year (So Far)
Motley Fool
Fri, 05/18/18 - 10:00 pm
ASCO
Endocyte
Loxo Oncology
Blueprint Medicines
Nektar Therapeutics
Jounce Therapeutics

Pages